07:00 , Sep 1, 2016 |  BC Innovations  |  Distillery Techniques

Techniques: Transgenic BCL2-like 10 (BCL2L10; BLC-B)-expressing mouse model of multiple myeloma (MM)

Disease models TECHNOLOGY: Transgenics and knockouts Transgenic mice expressing human BCL2L10 could be useful for screening therapies to treat MM. Levels of BCL2L10 were higher in plasma B cells from MM patients than in B...
07:00 , May 8, 2000 |  BC Extra  |  Financial News

Aeterna raises $9.4 million

Aeterna (TSE:AEL), a developer of cancer therapies, raised C$14 million (US$9.4 million) through the sale of 1.06 million shares at C$13.25 (US$8.888). The offering, which has a 158,491-share overallotment, was underwritten by Yorkton Securities; HSBC...